News Archive
Displaying the 10 most recent press releases...
Tuesday, February 16, 2010
EntreMed Receives Orphan Drug Designation for ENMD-2076 in Leukemia
Thursday, February 4, 2010
EntreMed Raises Additional $2.5 Million in Registered Direct Offering
Wednesday, January 20, 2010
EntreMed Receives NASDAQ Staff Determination Letter Regarding Non-Compliance with Minimum Bid Price Rule and Requests Hearing
Tuesday, January 12, 2010
EntreMed Completes Registered Direct Offering of $2.5 Million in Common Stock
Friday, December 11, 2009
EntreMed Reports Receipt of Third Quarter Royalty Payment
Monday, November 16, 2009
EntreMed’s ENMD-2076 Active in Solid and Hematological Cancers
Tuesday, November 3, 2009
Data for EntreMed’s ENMD-2076 to be Presented at the Upcoming AACR-NCI-EORTC Conference
Thursday, August 6, 2009
EntreMed Reports Second Quarter 2009 Financial Results
Monday, June 1, 2009
EntreMed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients